Metoclopramide Hydrochloride Injection · DIN 02537397 · 5 mg/mL · injection solution (Preservative Free)
Limited Use, Reason for Use code 481, 657 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 481, 657 required
Write on scriptone applicable Reason for Use code, 481 or 657 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 481, 657
Reason for Use code 481
For the management of patients receiving palliative care*.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
*The patient must have a progressive life-limiting illness and require this medication for palliative purposes.
Reason for Use code 657
For the treatment of patients receiving care at home* who have failed or are unable to tolerate oral alternatives, and who require an injectable option to manage their condition.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
*e.g., home care recipients, long-term care home residents.
1 brand, same coverage
Metoclopramide Hydrochloride Injection · DIN 02537397
Manufacturer: Jamp Pharma Corporation; listing date 2024-04-30
Health Canada: Marketed since 2024-02-08 · brand METOCLOPRAMIDE HYDROCHLORIDE INJECTION · ATC A03FA01 METOCLOPRAMIDE · form Solution · route Intramuscular, Intravenous · ingredients METOCLOPRAMIDE DIHYDROCHLORIDE (METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE) 5 MG/ML · company Jamp pharma corporation · schedule Prescription
Metoclopramide Hydrochloride Injection: Formulary list price $2.37 per unit (the source does not state the unit; exact figure $2.3748). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02537397)
Source record
DIN 02537397: Metoclopramide Hydrochloride Injection
Raw flags: sec12=Y, sec3=Y
Item: 564000082; group id 683; item number 1701; lccId 00271; manufacturer id JPC
Source form: Inj Sol (Preservative Free); strength: 5mg/mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $2.3748; ministry $2.3748
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02537397
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102611
Interchangeable products
Metoclopramide HCL Injection · DIN 02185431 · $2.3748
Shortage status: not checked (no credentials)